Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Source And Potency Of Stem Cells

Source And Potency Of Stem Cells

Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...

Adult Stem Cells

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously renew...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis.

Journal of neurology·2021

Same author

Axonal motor protein KIF5A and associated cargo deficits in multiple sclerosis lesional and normal-appearing white matter.

Neuropathology and applied neurobiology·2016

Same author

Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2013

Same author

Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort.

Neurology·2011

Same author

The relationship between relapse, impairment and disability in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2011

Same author

Fusion between human mesenchymal stem cells and rodent cerebellar Purkinje cells.

Neuropathology and applied neurobiology·2010

Same journal

Periodontitis-Associated Circulating EVs Promote Colorectal Cancer Progression via Carnosine-Mediated Acidosis Adaptation.

Cell proliferation·2026

Same journal

PLIN5 Protects Against Ang II-Induced Podocyte Lipotoxicity by Interacting With FKBP8 and Preserving Lipid Droplet-Mitochondria Contact.

Cell proliferation·2026

Same journal

Unveiling Gut Homeostasis Disruption in Sepsis: Towards an Integrated Mechanistic and Translational Roadmap.

Cell proliferation·2026

Same journal

The E-cadherin-Wnt-mir-994 Axis Repurposes a Cadherin Switch for Niche Robustness and Germline Stem Cell Maintenance.

Cell proliferation·2026

Same journal

A Multicellular Coordinated Network Driving Lymphovascular Space Invasion in Endometrioid Endometrial Carcinoma.

Cell proliferation·2026

Same journal

RETRACTION: Long Non-Coding RNA HCG11 Modulates Glioma Progression Through Cooperating With miR-496/CPEB3 Axis.

Cell proliferation·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 2, 2026

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

Adult stem cells and multiple sclerosis.

¹Department of Neurology, Frenchay Hospital, University of Bristol, UK. n.j.scolding@bristol.ac.uk

Cell Proliferation

|April 13, 2011

Summary

This summary is machine-generated.

Multiple sclerosis (MS) cell therapy is exploring new avenues beyond replacing myelin-forming cells. Bone marrow-derived stem cells show promise for treating this disabling neurological condition due to their reparative properties.

More Related Videos

Surgical Transplantation of Mouse Neural Stem Cells into the Spinal Cords of Mice Infected with Neurotropic Mouse Hepatitis Virus

Surgical Transplantation of Mouse Neural Stem Cells into the Spinal Cords of Mice Infected with Neurotropic Mouse Hepatitis Virus

Published on: July 10, 2011

Growing Neural Stem Cells from Conventional and Nonconventional Regions of the Adult Rodent Brain

Growing Neural Stem Cells from Conventional and Nonconventional Regions of the Adult Rodent Brain

Published on: November 18, 2013

Related Experiment Videos

Last Updated: Jun 2, 2026

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

Surgical Transplantation of Mouse Neural Stem Cells into the Spinal Cords of Mice Infected with Neurotropic Mouse Hepatitis Virus

Surgical Transplantation of Mouse Neural Stem Cells into the Spinal Cords of Mice Infected with Neurotropic Mouse Hepatitis Virus

Published on: July 10, 2011

Growing Neural Stem Cells from Conventional and Nonconventional Regions of the Adult Rodent Brain

Growing Neural Stem Cells from Conventional and Nonconventional Regions of the Adult Rodent Brain

Published on: November 18, 2013

Area of Science:

Neuroscience
Regenerative Medicine
Immunology

Background:

Multiple sclerosis (MS) is a disabling neurological disease causing myelin sheath damage and nerve cell loss.
The exact cause of MS is unknown, but autoimmune responses against myelin and oligodendrocytes are implicated.
Current cell therapy approaches for MS face challenges, including risks associated with embryonic stem cells.

Purpose of the Study:

To evaluate the potential of cell therapy for multiple sclerosis (MS).
To explore alternative stem cell sources beyond those initially considered for MS treatment.
To investigate the broader reparative capabilities of stem cells in the context of MS pathology.

Main Methods:

Review of current understanding of MS pathology and cell therapy efforts.
Analysis of the limitations and risks associated with embryonic stem cell therapies.
Assessment of the potential therapeutic properties of bone marrow-derived stem cells for MS.

Main Results:

Embryonic stem cells, while capable of generating oligodendrocytes, pose risks like tumor formation, hindering clinical application.
Bone marrow-derived stem cells are increasingly recognized for their diverse reparative functions.
The complexity of MS damage suggests therapies need to address more than just myelin replacement.

Conclusions:

Successful cell therapy for MS may require stem cells with multifaceted reparative capabilities.
Bone marrow-derived mesenchymal stem cells present a promising avenue for developing novel cell-based treatments for MS.
Further research into the reparative properties of adult stem cells is warranted for MS therapeutic development.